De Vries RRP, Faber J-C, Eds. Appendix B: Proposed standard definitions for surveillance of non infectious adverse transfusion reactions. In: Hemovigilance: an effective tool for improving transfusion safety. Oxford, UK: Wiley-Blackwell, 2012:351–9.Search in Google Scholar
2015 Annual SHOT Report. https://www.shotuk.org/wp-content/uploads/SHOT-2015-Annual-Report-Web-Edition-Final-bookmarked.pdf. Accessed 16 February 2017.Search in Google Scholar
FDA. Fatalities reported to the FDA following blood collection. 2015. http://www.fda.gov/downloads/Biologics BloodVaccines/SafetyAvailability/ReportaProblem TransfusionDonationFatalities/UCM518148.pdf. Accessed 23 April 2016.Search in Google Scholar
Agence nationale de sécurité du médicament et des produits de santé. Rapport d’activité hémovigilance 2015. http://ansm.sante.fr/var/ansm_site/storage/original/application/5c7cbc2890a1d5e436e11bd65e9ec512.pdf Accessed 16 February 2017.Search in Google Scholar
Fehily D, Strong DM, Minutoli D, et al. Sharing vigilance experience and knowledge globally: a preliminary overview of the Notify Library. Cells Tissues Organs 2013;16:117–25.Search in Google Scholar
